News Summary

• "We think that in some countries the product could be launched under accelerated approval by 2025," he said in an interview.Unlike conventional vaccines, so-called therapeutic vaccines treat rather than prevent a disease..
• "We have one in two people, compared to the best product on the market, who survive," he said, "which in oncology is huge..
• The more time passes, the more you see that advantage" said Bancel, noting that the rate of side effects hadn't increased..